These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy. Hammed A, Matagrin B, Spohn G, Prouillac C, Benoit E, Lattard V. J Biol Chem; 2013 Oct 04; 288(40):28733-42. PubMed ID: 23928358 [Abstract] [Full Text] [Related]
15. Avian interspecific differences in VKOR activity and inhibition: Insights from amino acid sequence and mRNA expression ratio of VKORC1 and VKORC1L1. Nakayama SMM, Morita A, Ikenaka Y, Kawai YK, Watanabe KP, Ishii C, Mizukawa H, Yohannes YB, Saito K, Watanabe Y, Ito M, Ohsawa N, Ishizuka M. Comp Biochem Physiol C Toxicol Pharmacol; 2020 Feb 04; 228():108635. PubMed ID: 31639498 [Abstract] [Full Text] [Related]
17. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors. Wallin R, Wajih N, Hutson SM. Vitam Horm; 2008 Feb 04; 78():227-46. PubMed ID: 18374197 [Abstract] [Full Text] [Related]
18. VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues. Lacombe J, Ferron M. Nutrients; 2018 Jul 26; 10(8):. PubMed ID: 30050002 [Abstract] [Full Text] [Related]
20. Determination of the warfarin inhibition constant Ki for vitamin K 2,3-epoxide reductase complex subunit-1 (VKORC1) using an in vitro DTT-driven assay. Bevans CG, Krettler C, Reinhart C, Tran H, Koßmann K, Watzka M, Oldenburg J. Biochim Biophys Acta; 2013 Aug 26; 1830(8):4202-10. PubMed ID: 23618698 [Abstract] [Full Text] [Related] Page: [Next] [New Search]